‹ All Posts
Dharmesh Bhatt

5 hours ago · SEBI Registration INH000009685

Q2FY27 Quarterly Result Announced for Panacea Biotec Ltd.

**** Consolidated Financial Highlights: **** Revenue from operations: In Q2FY27, consolidated revenue from operations stood at Rs 18,967 lakh, declining by 4.96% QoQ from Rs 19,957 lakh in Q1FY27 and increasing by 34.39% YoY from Rs 14,113 lakh in Q2FY26. For H1FY27, consolidated revenue from operations grew by 26.45% YoY to Rs 38,924 lakh compared to Rs 30,783 lakh in H1FY26. Profit after tax (PAT): In Q2FY27, consolidated PAT jumped by 441.36% QoQ to Rs 1,191 lakh from Rs 220 lakh in Q1FY27, swinging to a profit YoY against a net loss of Rs 1,401 lakh in Q2FY26. For H1FY27, consolidated PAT stood at Rs 1,411 lakh compared to a net loss of Rs 1,005 lakh in H1FY26. ---- Standalone Financial Highlights: ---- Revenue from operations: In Q2FY27, standalone revenue from operations stood at Rs 12,669 lakh, decreasing by 5.95% QoQ from Rs 13,471 lakh in Q1FY27 and increasing by 39.51% YoY from Rs 9,081 lakh in Q2FY26. For H1FY27, standalone revenue from operations increased by 28.73% YoY to Rs 26,140 lakh from Rs 20,306 lakh in H1FY26. Total income: In Q2FY27, standalone total income stood at Rs 13,310 lakh, declining by 5.45% QoQ from Rs 14,077 lakh in Q1FY27 and rising by 40.97% YoY from Rs 9,442 lakh in Q2FY26. For H1FY27, standalone total income grew by 29.42% YoY to Rs 27,387 lakh from Rs 21,162 lakh in H1FY26. . Profit after tax (PAT): In Q2FY27, standalone PAT surged by 673.38% QoQ to Rs 1,075 lakh from Rs 139 lakh in Q1FY27, swinging to a profit YoY from a net loss of Rs 1,564 lakh in Q2FY26. For H1FY27, standalone PAT reached Rs 1,214 lakh compared to a net loss of Rs 2,234 lakh in H1FY26. Read Disclaimer /Disclosure : link is in Bio

#FundamentalViews#StockInNews
85 likes·75 comments